Literature DB >> 4040769

Cystic fluid-platinum kinetics in ovarian cancer patients: relevance to cis-dichlorodiammine platinum (II) sensitivity testing in vitro.

M D Shelley, R G Fish, M Adams, I Kerby.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4040769      PMCID: PMC1977101          DOI: 10.1038/bjc.1985.188

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  8 in total

1.  "Send this patient's tumor for culture and sensitivity".

Authors:  D D Von Hoff
Journal:  N Engl J Med       Date:  1983-01-20       Impact factor: 91.245

2.  Total body clearance and platinum accumulation in patients treated with cis-dichlorodiammine platinum (II)

Authors:  R G Fish; M D Shelley; H Griffiths
Journal:  Ther Drug Monit       Date:  1984       Impact factor: 3.681

3.  Pharmacokinetics of free and total platinum species after short-term infusion of cisplatin.

Authors:  J B Vermorken; W J van der Vijgh; I Klein; A A Hart; H E Gall; H M Pinedo
Journal:  Cancer Treat Rep       Date:  1984-03

Review 4.  In vitro methods to predict for patient response to chemotherapy.

Authors:  D D Von Hoff; L Weisenthal
Journal:  Adv Pharmacol Chemother       Date:  1980

5.  Pharmacologic studies of anticancer drugs with the human tumor stem cell assay.

Authors:  D S Alberts; S E Salmon; H S Chen; T E Moon; L Young; E A Surwit
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

6.  Effect of mannitol and plasma on the cytotoxicity of cisplatin.

Authors:  E E Holdener; C H Park; R J Belt; R L Stephens; B Hoogstraten
Journal:  Eur J Cancer Clin Oncol       Date:  1983-04

7.  Single-agent cis-platinum therapy for advanced ovarian cancer.

Authors:  D M Gershenson; J T Wharton; J Herson; C L Edwards; F N Rutledge
Journal:  Obstet Gynecol       Date:  1981-10       Impact factor: 7.661

8.  In vitro sensitivity of human ovarian tumours to chemotherapeutic agents.

Authors:  A P Wilson; F E Neal
Journal:  Br J Cancer       Date:  1981-08       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.